Skip to main content
. 2020 Jul 20;15:1201–1212. doi: 10.2147/CIA.S254885

Figure 7.

Figure 7

Estrogen negatively regulates Cxcl9 secretion in osteoblasts. (A) qPCR analysis of Cxcl9 mRNA in primary osteoblasts treated with vehicle, estradiol or fulvestrant (estrogen receptor antagonist). (B) Western blot of Cxcl9 in primary osteoblasts. (C) Cxcl9 concentrations assessed by ELISA in supernatant of primary osteoblasts treated with vehicle, estradiol or fulvestrant. n=5 per group. Data are shown as mean ± s.d. *P < 0.05, **P < 0.01 (Student’s t-test).